Royalty Pharma Ownership | Who Owns Royalty Pharma?


OverviewForecastRevenueFinancialsChartTranscripts

Royalty Pharma Ownership Summary


Royalty Pharma is owned by 80.59% institutional investors, 8.74% insiders, and 10.68% retail investors. Morgan stanley is the largest institutional shareholder, holding 9.84% of RPRX shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 2.77% of its assets in Royalty Pharma shares.

RPRX Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockRoyalty Pharma80.59%8.74%10.68%
SectorHealthcare Stocks 488.17%11.08%-399.26%
IndustryBiotech Stocks 306.59%11.10%-217.69%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Morgan stanley44.13M9.84%$1.16B
Vanguard group37.35M8.34%$952.90M
Blackrock funding, inc. /de25.43M6.00%$916.20M
Fmr26.38M5.89%$672.94M
Capital investors21.88M5.17%$788.36M
Blackrock23.02M5.13%$606.97M
Baillie gifford14.13M3.16%$360.57M
Swedbank ab12.16M2.87%$438.03M
State street9.49M2.11%$250.17M
Geode capital management7.31M1.63%$186.85M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
New south capital management2.89M5.04%$104.00M
Patient capital management2.99M4.86%$107.66M
Cutter capital management, lp356.89K4.84%$11.11M
Regal partners1.35M4.10%$48.47M
Caledonia (private) investments pty6.44M3.69%$232.20M
Torray investment partners688.78K3.60%$24.82M
Menlo advisors131.32K2.55%$4.73M
Ctf capital management, lp100.00K2.13%$3.60M
Inlet private wealth234.84K2.08%$8.46M
Cannon global investment management25.00K1.84%$900.75K

Top Buyers

HolderShares% AssetsChange
Capital investors21.88M0.14%21.88M
Norges bank4.88M0.02%4.88M
Blackrock23.02M0.01%1.81M
Bnp paribas arbitrage, snc1.64M0.02%1.64M
Arrowstreet capital, limited partnership2.98M0.08%1.62M

Top Sellers

HolderShares% AssetsChange
Viking global investors lp2.60M0.27%-7.97M
Unisphere establishment---5.00M
Gmt capital---2.38M
Siguler guff advisers---2.37M
Millennium management309.17K0.01%-2.11M

New Positions

HolderShares% AssetsChangeValue
Capital investors21.88M0.14%21.88M$788.36M
Norges bank4.88M0.02%4.88M$124.50M
Bnp paribas arbitrage, snc1.64M0.02%1.64M$41.96M
Capital, inc./ca/661.54K0.23%661.54K$23.84M
Cartesian growth387.57K0.24%387.57K$9.89M

Sold Out

HolderChange
Financial gravity asset management-2.00
Central trust-3.00
Harbor investment advisory-4.00
New millennium group-11.00
Td waterhouse canada-13.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 2025456-1.30%341,289,0057.83%801.51%248-1482.07%
Mar 31, 20253-99.28%2,405,220-99.25%-0.01%1-99.58%2-98.51%
Dec 31, 2024382-3.78%305,326,416-0.72%681.45%210-2.78%1296.61%
Sep 30, 20243943.14%307,455,539-2.73%681.40%2146.47%120-4.76%
Jun 30, 2024377-1.57%316,067,5732.80%701.49%201-8.22%1236.03%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard US Total Market Shares ETF12.01M2.77%-167.60K
Vanguard Total Stock Mkt Idx Inv11.25M2.60%-258.49K
Vanguard Mid Cap Index Institutional7.99M1.85%86.30K
Capital Group New Perspective Comp7.08M1.68%7.08M
American Funds New Perspective A7.08M1.68%7.08M
Morgan Stanley Inst Growth I5.94M1.38%580.21K
Morgan Stanley Growth5.94M1.38%261.46K
Morgan Stanley Growth SMA5.94M1.38%261.46K
MS INVF US Advantage I5.41M1.25%-
MS INVF US Growth I4.59M1.06%-45.55K

Recent Insider Transactions


DateNameRoleActivityValue
Aug 11, 2025Norden Gregory-Sell$1.21M
Jan 03, 2024RIGGS RORY B-Sell$5.53M
Jan 02, 2024RIGGS RORY B-Sell$6.71M
Jan 04, 2024RIGGS RORY B-Sell$983.50K
Dec 29, 2023Avara Management Ltd-Sell$1.85M

Insider Transactions Trends


DateBuySell
2025 Q3-1
2025 Q2--
2025 Q1--
2024 Q4--
2024 Q3--

RPRX Ownership FAQ


Who Owns Royalty Pharma?

Royalty Pharma shareholders are primarily institutional investors at 80.59%, followed by 8.74% insiders and 10.67% retail investors. The average institutional ownership in Royalty Pharma's industry, Biotech Stocks , is 306.59%, which Royalty Pharma falls below.

Who owns the most shares of Royalty Pharma?

Royalty Pharma’s largest shareholders are Morgan stanley (44.13M shares, 9.84%), Vanguard group (37.35M shares, 8.34%), and Blackrock funding, inc. /de (25.43M shares, 6.00%). Together, they hold 24.19% of Royalty Pharma’s total shares outstanding.

Does Blackrock own Royalty Pharma?

Yes, BlackRock owns 5.13% of Royalty Pharma, totaling 23.02M shares as of Jun 2024. This represents 0.01% of BlackRock's total assets, with a market value of 606.97M$. In the last quarter, BlackRock increased its holdings by 1.81M shares, a 8.54% change.

Who is Royalty Pharma’s biggest shareholder by percentage of total assets invested?

New south capital management is Royalty Pharma’s biggest shareholder by percentage of total assets invested, with 5.04% of its assets in 2.89M Royalty Pharma shares, valued at 104M$.

Who is the top mutual fund holder of Royalty Pharma shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of Royalty Pharma shares, with 2.77% of its total shares outstanding invested in 12.01M Royalty Pharma shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools